Thiazolidine-4-carboxylic acid, sodium salt
Grundinformationen
- CAS
35041-11-3- Standard-SMILES
O=C([O-])C1CSCN1.[Na+]- InChIKey
YWLXEQKAKDKVBQ-UHFFFAOYSA-M- Summenformel
- C4H6NNaO2S
- Durchschnittliche Molmasse
- 155,15 g/mol
- Monoisotopische Masse
- 155,00169389
Namen und Bezeichner
- Bevorzugter Name
- Thiazolidine-4-carboxylic acid, sodium salt
- IUPAC
- sodium 1,3-thiazolidine-4-carboxylate
Namen und Synonyme
RefChem:898129thiazolidine-4-carboxylic acid, sodium saltTimonacic sodium4-Thiazolidinecarboxylic acid, sodium saltSodium 4-thiazolidinecarboxylate35041-11-3Boc-Thz-OH;Boc-L-thioprolineEINECS 252-332-2B33MAZ89JCSCHEMBL30863631YWLXEQKAKDKVBQ-UHFFFAOYSA-MAKOS003272434
Weitere Namen anzeigen
SODIUM THIAZOLIDINE-4-CARBOXYLATE4-Thiazolidinecarboxylic acid, monosodium salt4-Thiazolidinecarboxylic acid, sodium salt (1:1), (4R)-
Datenbank-Bezeichner
- CAS
35041-11-3- PubChem CID
- 23686667
- UNII
- B33MAZ89JC
- EC Number
- 252-332-2
- Nikkaji
- J289.886A
Eigenschaften
Berechnete Struktureigenschaften
- Polarare Oberfläche (TPSA)
- 77,5 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 4
- Frei drehbare Bindungen
- 1
- Schwere Atome
- 9
- Formalladung
- 0
- Komplexität
- 111
Sicherheit und Regulatorisches
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
GHS-Klassifizierung
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Gefahrenhinweise
Hazard Classes and CategoriesAcute Tox. 4 (100%)
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological Classification
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
Agents counteracting or neutralizing the action of POISONS.
Substances that inhibit or prevent the proliferation of NEOPLASMS.
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.
Zugehörige Reaktionen
0
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Notizen zur Verbindung
Wird geladen…